ANIX - Anixa Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
10/30/2018
10/30/2017
10/30/2016
Cash flows from operating activities
Net Income
-14,862
-13,996
-5,009
-5,016
Depreciation & amortization
539
344
369
359
Deferred income taxes
-
-
-
-
Stock based compensation
8,571
8,911
1,709
905
Change in working capital
562
68
408
-161
Accounts receivable
-
-
-
0
Inventory
-
-
-
-
Accounts Payable
148
102
107
88
Other working capital
-4,607
-4,312
-3,827
-3,528
Other non-cash items
-
318
228
532
Net cash provided by operating activites
-4,425
-4,273
-3,797
-3,382
Cash flows from investing activities
Investments in property, plant and equipment
-182
-38
-30
-147
Acquisitions, net
-
-
-
-
Purchases of investments
-2,600
-4,250
-5,501
-1,900
Sales/Maturities of investments
3,250
5,750
2,751
3,550
Other investing activites
-
-
0
0
Net cash used for investing activites
468
1,462
-2,735
1,503
Cash flows from financing activities
Debt repayment
-
0
-3,000
-
Common stock issued
5,584
2,470
10,876
-
Common stock repurchased
-
0
-500
0
Dividends Paid
-
-
-
-
Other financing activites
-
-
0
-36
Net cash used privided by (used for) financing activities
5,763
2,528
7,383
-3
Net change in cash
1,806
-283
851
-1,881
Cash at beginning of period
2,591
3,339
2,488
4,369
Cash at end of period
4,397
3,056
3,339
2,488
Free Cash Flow
Operating Cash Flow
-4,425
-4,273
-3,797
-3,382
Capital Expenditure
-182
-38
-30
-147
Free Cash Flow
-4,607
-4,312
-3,827
-3,528